
Mabylon
Operator of a biotechnology company intended to harness the therapeutic potential of naturally occurring human antibodies to treat allergies, inflammation, and neurodegenerative diseases. The company ...
Valuation
$0
Share Price
N/A
Total Raised
$58.6M
Last Round
N/A